These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 10950749

  • 1. Which children should receive growth hormone treatment. Long term side effects possible with high doses.
    Betts P.
    Arch Dis Child; 2000 Aug; 83(2):176-8. PubMed ID: 10950749
    [No Abstract] [Full Text] [Related]

  • 2. Which children should receive growth hormone treatment. Reserve it for the GH deficient.
    Brook CG.
    Arch Dis Child; 2000 Aug; 83(2):176-8. PubMed ID: 10906033
    [No Abstract] [Full Text] [Related]

  • 3. Therapy of growth disorders.
    Ali O, Wyatt D.
    Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):3-8. PubMed ID: 21150587
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 5. Effects of short- and long-acting recombinant human growth hormone (PEG-rhGH) on left ventricular function in children with growth hormone deficiency.
    Wang CL, He Y, Liang L, Zou CC, Hong F, Dong GP, Pei J.
    Acta Paediatr; 2011 Jan; 100(1):140-2. PubMed ID: 20735363
    [No Abstract] [Full Text] [Related]

  • 6. [The biosynthetic human growth hormone (Somatonorm) in the treatment of children with growth hormone deficiency].
    Banićević M, Joksimović I, Zdravković D.
    Srp Arh Celok Lek; 1987 Jan; 115(1):25-39. PubMed ID: 3672230
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
    Peterkova V, Arslanoglu I, Bolshova-Zubkovskaya E, Romer T, Zdravkovic D, Kratzsch J, Ji HJ, Savoy C, Saenger P.
    Horm Res; 2007 Jan; 68(6):288-93. PubMed ID: 17627092
    [Abstract] [Full Text] [Related]

  • 8. Treatment approaches for growth failure.
    Rosenbloom AL.
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):48-50. PubMed ID: 18806725
    [No Abstract] [Full Text] [Related]

  • 9. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Sep; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood.
    Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM.
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):589-97. PubMed ID: 17590170
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of growth hormone therapy in childhood.
    Bowlby DA, Rapaport R.
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():68-77. PubMed ID: 16456485
    [Abstract] [Full Text] [Related]

  • 13. Adult-onset growth hormone deficiency: causes, complications and treatment options.
    Mathioudakis N, Salvatori R.
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):352-8. PubMed ID: 18594276
    [Abstract] [Full Text] [Related]

  • 14. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
    Mohn A, Marzio D, Giannini C, Capanna R, Marcovecchio M, Chiarelli F.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
    [Abstract] [Full Text] [Related]

  • 15. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS, Scheinowitz M, Laron Z.
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [Abstract] [Full Text] [Related]

  • 16. [Results of treatment with recombinant human growth hormone in children with growth retardation in end-stage renal disease].
    Sieniawska M, Pańczyk-Tomaszewska M, Ziółkowska H, Jedrzejowski A, Leszczyńska B, Dyras P, Kałuzyńska A, Makulska I, Pietrzyk JA, Rubik J, Siteń G, Stachowski J, Szprynger K, Zurowska A, Roszkowska-Blaim M.
    Pol Merkur Lekarski; 2001 Apr; 10(58):263-6. PubMed ID: 11434172
    [Abstract] [Full Text] [Related]

  • 17. Adverse effects of growth hormone replacement therapy in children.
    Souza FM, Collett-Solberg PF.
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):559-65. PubMed ID: 22218437
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Individualization of growth hormone therapy.
    Johnston LB.
    Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):517-24. PubMed ID: 18538290
    [Abstract] [Full Text] [Related]

  • 20. A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature.
    Elder CJ, Barton JS, Brook CG, Preece MA, Dattani MT, Hindmarsh PC.
    Horm Res; 2008 Jun; 70(2):89-92. PubMed ID: 18547955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.